EN DE

T Scientific Co (057680) Fair Value & Analysis

Technology · KR · Market cap 26.6B KRW

TS T Scientific Co 057680 · KQ
Price1,650 KRW
Fair Value293.34 KRW
Upside-82.2%
Quality50/100
Watch T Scientific Co for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -34.4% net margin
Low debt · generates free cash flow
Trails peers (1/8)
Narrow moat 10/100
Evidence: Medium Range 283.24 KRW – 302.04 KRW Share as image

Fair value as of: Jul 20, 2026

From 13 valuation models · updated 21 days ago

Share price −17.7% over the past month.

A solid business, but screening 82% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (302.04 KRW). The favourable scenario is already priced in.
  • Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.
  • The models converge in a tight band (283.24 KRW to 302.04 KRW), unusually little disagreement for a valuation.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

29,950 KRW 1,500 KRW Fair Value 293.34 KRW Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.

How to read this chart

60‑month range 1,500 KRW – 29,950 KRW · fair‑value band 283.24 KRW – 302.04 KRW · the 1,650 KRW price screens above the 293.34 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 20, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

T Scientific Co (057680) currently trades at 1,650 KRW, while our model-based Fair Value estimate is 293.34 KRW, implying the stock looks roughly 82.2% overvalued today. The Quality Score stands at 50/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, T Scientific Co generated revenue of 35.0B KRW at a net margin of -34.4%. Revenue declined 17.3% year over year. Net debt stands at 2.4B KRW. Fundamentals as of Jul 20, 2026

Our scenario range runs from 283.24 KRW (bear case) to 302.04 KRW (bull case); at 1,650 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 80% below its 52-week high, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at 8% fair-value upside, at -82%, 057680 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 489.77 KRW 768.32 KRW 1,282 KRW 80
Rev-Margin DCF 353.40 KRW 443.93 KRW 574.51 KRW 74
ROIC Compounder 286.75 KRW 298.07 KRW 307.98 KRW 72
All 13 models by family
DCF Models
FCF DCF 500.49 KRW 713.03 KRW 1,287 KRW 38
5Y Revenue Exit 353.40 KRW 438.12 KRW 571.09 KRW 39
5Y EBITDA Exit 556.79 KRW 889.54 KRW 1,405 KRW 41
10Y Revenue Exit 394.26 KRW 506.49 KRW 650.80 KRW 36
10Y EBITDA Exit 538.55 KRW 873.98 KRW 1,469 KRW 37
Earnings-Based
EPV 286.75 KRW 298.07 KRW 307.98 KRW 59
Multiples
EV/EBIT 325.81 KRW 361.47 KRW 397.14 KRW 53
EV/EBITDA 591.67 KRW 715.96 KRW 840.24 KRW 54
EV/Revenue 290.94 KRW 321.85 KRW 352.75 KRW 43
Asset-Based
NCAV (Graham) 2,553 KRW 3,421 KRW 5,106 KRW 50
Growth DCF
Growth DCF 489.77 KRW 768.32 KRW 1,282 KRW 80
Rev-Margin DCF 353.40 KRW 443.93 KRW 574.51 KRW 74
Economic Profit
ROIC Compounder 286.75 KRW 298.07 KRW 307.98 KRW 72

Widest divergence: Asset-Based (3,421 KRW) versus Earnings-Based (298.07 KRW). Highest evidence: Growth DCF (80).

Notify me when 057680 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 35.0B KRW
Revenue growth (YoY) -17.3%
Net margin -34.4%
Return on equity -876%
Free cash flow 622M KRW FY2025
Operating margin -23.0%
More key figures
Net debt 2.4B KRW FY2024

Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 50/100

Of which business quality 49 · Market factors (momentum, volatility) 8

Profitability 9
Margins and returns on capital today
Quality Growth 35
Are margins and returns improving?
Cashflow 43
Earnings quality: real cash, not paper profit
Fin. Strength 44
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 26
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

T Scientific Co., Ltd. engages in wired/mobile communication and broadcast business in Korea and internationally. The company offers mobile broadcast service, which is enabled by Cell Broadcasting Service technology; Smart DMB that is an integrated DMB application, which enables customers to watch TV or radio with DMB-embedded smartphones, as well as …

Full company description

T Scientific Co., Ltd. engages in wired/mobile communication and broadcast business in Korea and internationally. The company offers mobile broadcast service, which is enabled by Cell Broadcasting Service technology; Smart DMB that is an integrated DMB application, which enables customers to watch TV or radio with DMB-embedded smartphones, as well as various value added services through telecommunication network in the same screen; and Smart Health Care applications. It is also involved in platform business. The company was founded in 1998 and is based in Seoul, South Korea.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

T Scientific Co reported revenue of 36.4B KRW in FY2025 versus 10.1B KRW in FY2021, a compound +37.8%/yr. Reported net income was −1.3B KRW in FY2025.

Growth Quality 48/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
36.4B KRW
Latest YoY
−15.5%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+61.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+30.7%
Avg. growth/yr (16Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.9%
Revenue +37.8%/yr
FY21 10.1B KRW
FY22 8.7B KRW
FY23 26.8B KRW
FY24 43.0B KRW
FY25 36.4B KRW
Net income
FY21 −3.2B KRW
FY22 −11.1B KRW
FY23 −45.4B KRW
FY24 2.2B KRW
FY25 −1.3B KRW

057680 screens 82% overvalued. Compare with KINX, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "T Scientific Co Fair Value". https://www.fairvalue-calculator.com/stock/057680

Peer Group

Software & IT Services · 32 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 50 · Below median
Fair Value upside −82% · Bottom 25%
Return on assets -17% · Bottom 25%
Net margin (TTM) -34% · Bottom 25%
Operating margin (TTM) -23% · Bottom 25%
Revenue growth -17% · Below median
Debt / equity 0.03× · Lower than median

Valuation Multiples vs Software & IT Services median · lower = cheaper

P/FCF 0.0× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 0 · sector 28
PAST 0 · sector 74
HEALTH 99 · sector 99
DIVIDEND 0 · sector 26

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Software & IT Services stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).

Stock Price Fair Value vs Fair Value
KINX, Inc 093320 128,700 KRW 74,800 KRW -42%
Wemade Co 112040 15,160 KRW 9,700 KRW -36%
AfreecaTV Co 067160 45,200 KRW 176,746 KRW +291%
Gabia Inc 079940 44,050 KRW 24,232 KRW -45%
Hancom Inc 030520 15,890 KRW 31,596 KRW +99%
Webzen Inc 069080 11,750 KRW 12,748 KRW +8%
NEOWIZ 095660 17,010 KRW 46,407 KRW +173%
Wemade Max Co 101730 3,665 KRW 825.00 KRW -77%
GalaxiaMoneytree Co 094480 4,600 KRW 3,778 KRW -18%
DAEA TI Co 045390 2,475 KRW 4,958 KRW +100%

Compare T Scientific Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is T Scientific Co (057680) overvalued or undervalued?
As of Jul 20, 2026, our model estimates a fair value of 293.34 KRW versus a price of 1,650 KRW, about −82% (overvalued).
What is the fair value of 057680?
Our model-based fair value for T Scientific Co is 293.34 KRW (as of Jul 20, 2026), built from audited fundamentals. The current price is 1,650 KRW.
What is the quality score of 057680?
T Scientific Co has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of T Scientific Co (057680)?
T Scientific Co reported trailing-twelve-month revenue of about 35.0B KRW (latest available figure, as of Jul 20, 2026).
What is the net profit margin of 057680?
The net profit margin of T Scientific Co is about -34.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track T Scientific Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.